IbrutinibFatigue following off label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1766卷 / 1期

关键词：

D O I：

10.1007/s40278-019-66229-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：157 / 157

相关论文

共 50 条

[1] NivolumabFatigue following off label use: case report
Reactions Weekly, 2017, 1642 (1) : 228 - 228
[2] MethylprednisoloneBacteraemia following off label use: case report
Reactions Weekly, 2021, 1872 (1) : 310 - 310
[3] FosfomycinNausea following an off label use: case report
Reactions Weekly, 2019, 1745 (1) : 132 - 132
[4] RituximabNeutropenia following off label use: case report
Reactions Weekly, 2021, 1836 (1) : 687 - 687
[5] CediranibPolycythaemia following off label use : case report
Reactions Weekly, 2020, 1796 (1) : 68 - 68
[6] DexmedetomidineBradycardia following off label use: case report
Reactions Weekly, 2022, 1935 (1) : 182 - 182
[7] VenetoclaxMyelosuppression following off label use: case report
Reactions Weekly, 2021, 1842 (1) : 361 - 361
[8] CinacalcetHyperphosphataemia following off label use: case report
Reactions Weekly, 2019, 1769 (1) : 121 - 121
[9] HydroxychloroquineRash following off label use: case report
Reactions Weekly, 2020, 1822 (1) : 154 - 154
[10] MetreleptinHypoglycaemia following off label use: case report
Reactions Weekly, 2022, 1924 (1) : 287 - 287

← 1 2 3 4 5 →